Lv1
30 积分 2021-11-29 加入
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
15小时前
待确认
Advancing targeted protein degradation for cancer therapy
1个月前
已完结
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
1个月前
已完结
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
5个月前
已完结
Colorectal cancer
5个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
6个月前
已完结
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
6个月前
已完结
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
6个月前
已关闭
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease
8个月前
已完结
Translational PK–PD for targeted protein degradation
11个月前
已完结
TotalSegmentator: robust segmentation of 104 anatomical structures in CT images
3年前
已采纳
Development and validation of a prognostic nomogram for myocardial infarction patients in intensive care units: a retrospective cohort study
3年前
已采纳
皖公网安备34019202002308
